Lesional Overexpression of Matrix Metalloproteinase-9 Promotes Intraplaque Hemorrhage in Advanced Lesions But Not at Earlier Stages of Atherogenesis
- 1 February 2006
- journal article
- research article
- Published by Wolters Kluwer Health in Arteriosclerosis, Thrombosis, and Vascular Biology
- Vol. 26 (2) , 340-346
- https://doi.org/10.1161/01.atv.0000197795.56960.64
Abstract
Background— Matrix metalloproteinase-9 (MMP-9) is involved in atherosclerosis and elevated MMP-9 activity has been found in unstable plaques, suggesting a crucial role in plaque rupture. This study aims to assess the effect of MMP-9 on plaque stability in apolipoprotein E-deficient mice at different stages of plaque progression. Methods and Results— Atherosclerotic lesions were elicited in carotid arteries by perivascular collar placement. MMP-9 overexpression in intermediate or advanced plaques was effected by intraluminal incubation with an adenovirus (Ad.MMP-9). A subset was coincubated with Ad.TIMP-1. Mock virus served as a control. Plaques were analyzed histologically. In intermediate lesions, MMP-9 overexpression induced outward remodeling, as shown by a 30% increase in media size (p=0.03). In both intermediate and advanced lesions, prevalence of vulnerable plaque morphology tended to be increased. Half of MMP-9–treated lesions displayed intraplaque hemorrhage, whereas in controls and the Ad.MMP-9/Ad.TIMP-1 group this was 8% and 16%, respectively (p=0.007). Colocalization with neovessels may point to neo-angiogenesis as a source for intraplaque hemorrhage. Conclusion— These data show a differential effect of MMP-9 at various stages of plaque progression and suggest that lesion-targeted MMP-9 inhibition might be a valuable therapeutic modality in stabilizing advanced plaques, but not at earlier stages of lesion progression. The effect of MMP-9 overexpression at various stages of atherosclerotic lesion development was studied in apoE-deficient mice. In intermediate lesions, MMP-9 results in outward remodeling. In advanced lesions this causes vulnerable plaque morphology accompanied with increased incidence of intraplaque hemorrhage.Keywords
This publication has 31 references indexed in Scilit:
- Calcified Pleural Plaque Can Rupture Thoracic AortaCirculation, 2004
- Functional matrix metalloproteinase-9 polymorphism (C-1562T) associated with abdominal aortic aneurysmJournal of Vascular Surgery, 2003
- Matrix Metalloproteinases, Tissue Inhibitors of Matrix Metalloproteinases and Angiogenic Cytokines in Peripheral Blood of Patients with Thyroid CancerThyroid®, 2002
- Doxycycline Modulates Smooth Muscle Cell Growth, Migration, and Matrix Remodeling after Arterial InjuryThe American Journal of Pathology, 2002
- ApoE knockout mice expressing human matrix metalloproteinase-1 in macrophages have less advanced atherosclerosisJournal of Clinical Investigation, 2001
- Role of inflammation and metalloproteinases in plaque disruption and thrombosisVascular Medicine, 1998
- Development of recombinant adenoviruses that drive high level expression of the human metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 and -2 genes: Characterization of their infection into rabbit smooth muscle cells and human MCF-7 adenocarcinoma cellsMatrix Biology, 1996
- Elucidation off the role of plaque instability and rupture in acute coronary eventsThe American Journal of Cardiology, 1995
- Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques.Journal of Clinical Investigation, 1994
- Enhanced Expression of Vascular Matrix Metalloproteinases Induced In Vitro by Cytokines and in Regions of Human Atherosclerotic LesionsaAnnals of the New York Academy of Sciences, 1994